HOUSTON, July 28, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development ...
Scientists are supercharging T cells with multipotent stromal cells’ mitochondria to make them more ferocious invaders of the tumor microenvironment. An international collaboration between researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback